Form D · Biotechnology

ZYMOGENETICS INC

Seattle, WA · CIK 0001129425

Offering snapshot reported Nov 17, 2008 · SEC filing

Reported sold
$15.5M
Offering amount: $15.5M
Investors reported
Not reported
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Not reported
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 17, 2008Initial$15,510,000No comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
Not reported
Finders' fees
Not reported
Form D file number
021-65761

Source: Form D, filed Nov 17, 2008. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Bruce L.A. Carter, Ph.D. Director, Executive
Michael J. Dwyer Executive
Heather L. Franklin Executive
Darren R. Hamby Executive
James A. Harper Director
Judith A. Hemberger, Ph.D. Director
Vaughn B. Himes, Ph.D. Executive
David I. Hirsch, Ph.D. Director
James A. Johnson Executive
Jonathan S. Leff Director
David H. Mac Callum Director
Kurt Anker Nielsen Director
Nicole Onetto, M.D. Executive
Edward E. Penhoet, Ph.D. Director
Suzanne M. Shema, J.D. Executive
Lars Rebien Sorensen Director
Douglas E. Williams, Ph.D. Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1201 Eastlake Avenue East
Seattle, WA, 98102